AstraZeneca COVID-19 vaccine applies for full regulatory approval in Brazil


  • World
  • Saturday, 30 Jan 2021

FILE PHOTO: A test tube labelled "vaccine" in front of an AstraZeneca logo in this illustration taken, September 9, 2020. REUTERS/Dado Ruvic/Illustration/File Photo

RIO DE JANEIRO (Reuters) - Brazilian health regulator Anvisa said on Friday that a COVID-19 vaccine developed by Oxford University and AstraZeneca Plc had applied for full regulatory approval, in a positive development for the country's beleaguered vaccine rollout.

The submission, the first of its kind in Brazil, was made by the federally funded Fiocruz Institute, which will manufacture the British vaccine locally. A spokeswoman for AstraZeneca, whose vaccine is already approved for emergency use in Brazil, confirmed the submission.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In World

Haiti blasts Macron's criticism of transition council as 'unfriendly and inappropriate'
Cote d'Ivoire, EU sign new fishing agreement
North Korea's Kim accuses US of stoking tension, warns of nuclear war
Canada to give holiday tax break for groceries
U.S. stocks close higher
Slovak PM shooting suspect faces prolonged custody
Gas Leak prompts evacuation of 150 people in Prague
Nations strive for climate funding consensus as COP29 deadline nears
Biden's shift on missiles for Ukraine informed by North Korean troops in Kursk, Trump's election victory
Wall Street top regulator to leave SEC when Trump takes office

Others Also Read